DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online support, community stories, financial assistance
Adam Gardiner Fund Incorporation Blog
The Adam Gardiner Fund Incorporation (AGF) raises money to support the Westmead Amyloidosis Centre in the treatment of amyloidosis, a group of diseases that cause a buildup of abnormal protein in tissues and bodily organs. The Fund also supports clinical research and aims to raise awareness for these life-threatening diseases.
The Adam Gardiner Fund’s mission is to raise funds & awareness for amyloidosis while working within the structure of Westmead Hospitals Immunology Department and its Institute for Immunology & Allergy Research (IIAR).
Related Content
-
educationUnderstanding Amyloidosis: Etiology, Epidemiology, Pathophysiology, ManagementIntroduction: Amyloidosis is a heteroge...
-
educationAL Amyloidosis Presenting With Limb Girdle MyopathyAn elderly Caucasian man presented with ...
-
news & meetingsMayo Clinic Patient Symposium in Plasma Cell Disorders 2021: Patient and Family RegistrationMayo Clinic School of Continuous Profess...
-
educationPatisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisBackground: Patisiran, an investigation...
-
educationThe Lung in AmyloidosisAmyloidosis is a disorder caused by misf...
-
educationManagement of Systemic AL Amyloidosis: Recommendations of the Myeloma Foundation of Australia Medical and Scientific...Systemic AL amyloidosis is a plasma cell...
-
educationPrimary Brain Amyloidoma, Both a Neoplastic and a Neurodegenerative Disease: A Case ReportBackground: Scattered extracellular dep...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.